Why do some clinicians avoid methotrexate in people over 65?
Methotrexate is cleared by the kidneys and can build up in the body when kidney function declines with age. That raises the risk of toxic side effects, especially when combined with other medicines that affect kidney function or drug levels. [1]
What side effects are the main concern in older adults?
The most important risks are from “too much” methotrexate in the body or from low blood counts and liver effects. Older patients may have higher rates of treatment complications such as:
- Low white blood cells or other blood count problems (which can increase infection risk)
- Mouth sores or gastrointestinal irritation
- Liver enzyme elevations or liver toxicity with ongoing use
- Increased risk of serious toxicity if kidney function is reduced [1]
How do kidney function and drug interactions drive the recommendation?
Because kidney function often decreases with age, clinicians may need lower doses, slower titration, or closer monitoring. Methotrexate also has clinically relevant drug interactions; certain drugs can increase methotrexate exposure or add stress to the liver/kidneys, making toxicity more likely in older adults. This is why prescribers may be more cautious in people over 65. [1]
Does “not recommended” mean nobody over 65 can take it?
Not always. Many patients over 65 still receive methotrexate when benefits outweigh risks. In practice, clinicians decide based on:
- Current kidney function (often estimated by lab tests)
- The methotrexate dose and dosing schedule
- Other medicines the patient takes
- Baseline blood counts and liver tests
- How reliably monitoring can be done during treatment [1]
What monitoring usually helps make methotrexate safer in older adults?
When methotrexate is used in older adults, monitoring commonly includes periodic:
- Kidney function tests
- Liver tests
- Complete blood counts (to detect early bone-marrow suppression) [1]
Sources
[1] https://www.drugs.com/methotrexate.html